Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Detalles Bibliográficos
Autores principales: Mahalingam, Devalingam, Hanni, Salih, Serritella, Anthony V., Fountzilas, Christos, Michalek, Joel, Hernandez, Brian, Sarantopoulos, John, Datta, Paromitta, Romero, Ofelia, Achutan Pillai, Sureshkumar Mulampurath, Kuhn, John, Pollak, Michael, Thompson, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588661/
https://www.ncbi.nlm.nih.gov/pubmed/37861386
http://dx.doi.org/10.18632/oncotarget.28530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588661/
https://www.ncbi.nlm.nih.gov/pubmed/37861386
http://dx.doi.org/10.18632/oncotarget.28530

Ejemplares similares